8600 newborns with high genetic risks for the disease, and we plan to follow them for 15 years. we will be collecting biological samples and information about their lives, identification comfortable, of an infectious agent that triggers this auto immunity could lead to a vaccine to protect against this disorder. .. is conducting trials of promising therapies in newly diagnosed patients. now, the third handoff continues along a spectrum of disease progression and this next age of disease research shown in green focus is on people with established type one diabetes. and a high priority for this stage is a development of new tools and technologies to help people improve their blood glucose control because they can reduce diabetes complications by up to 70%. this is certainly an artificial pancreas that automatically links with close monitoring with insulin delivery to make a positive impact on people s health and their quality of life. and i.d. decay is supporting innovative, in